Letter From Egom Regarding Article, "High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy"

Circulation - United States
doi 10.1161/circulationaha.113.006477
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Management of Residual Risk After Statin Therapy

Atherosclerosis
Cardiovascular MedicineCardiology
2016English

High Density Lipoprotein Cholesterol and Risk of Death

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Combined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome

Circulation
Cardiovascular MedicinePhysiologyCardiology
2008English

Identification and Management of Vascular Risk: Beyond Low Density Lipoprotein Cholesterol

AAOHN Journal
2003English

Beyond LDL-Cholesterol: The Role of Low HDL-Cholesterol and Elevated TG in Residual Cardiovascular Risk Remaining After Statin Therapy

Journal of Managed Care Pharmacy
2008English

Short Communication: Risk of Elevated Total Cholesterol/High-Density Lipoprotein Cholesterol Ratio After Antiretroviral Therapy in HIV/Hepatitis C Virus Patients

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2012English

High-Density Lipoprotein Cholesterol as a Therapeutic Target for Residual Risk in Patients With Acute Coronary Syndrome

PLoS ONE
Multidisciplinary
2018English

MicroRNAs and High-Density Lipoprotein Cholesterol Metabolism

International Heart Journal
MedicineCardiovascular MedicineCardiology
2015English

From High-Density Lipoprotein Cholesterol to Measurements of Function

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy